An observational study in Coronary Occlusion, Coronary Artery Stenosis and Coronary Stenosis, sponsored by Seung-Jung Park. Terminated at 19 sites in Korea, Republic of. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2022-04-18.
Sponsored by Seung-Jung Park · Observational
This study evaluated the long-term outcome of patients with chronic total occlusion treated with percutaneous coronary intervention, medical treatment or coronary artery bypass grafting.
This study is connected with Decision-CTO trial(NCT01078051). Randomized subjects and registry group subjects from Decision-CTO trial continue 10 years follow-up on this study.
302 studies on the registry are indexed under Coronary Stenosis; 63 are open to participants now.
This study's enrollment of 4,006 is above the median of 200 across 132 observational studies indexed under Coronary Stenosis.
Browse Coronary Stenosis studies →Seung-Jung Park is the lead sponsor of 82 studies on the registry; 15 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with De novo chronic coronary occlusion ≥ 3months and reference diameter ≥ 2.5 mm on coronary angiography
Exclusion Criteria:
≥3 months chronic total occlusion on coronary angiography
Procedure: Percutaneous coronary intervention · Procedure: Coronary Artery Bypass Grafting · Drug: Medical treatment
Composite event of all cause death, myocardial infarction, stroke or all kinds of repeat revascularization
Time frame: 10 years
Event rate of all cause death
Time frame: 10 years
Event rate of acute myocardial infarction
Time frame: 10 years
Event rate of stroke
Time frame: 10 years
Event rate of repeat revascularization
Time frame: 10 years
Event rate of rehospitalization due to acute coronary syndrome
Time frame: 10 years
The rate change of left ventricular ejection fraction
Time frame: 10 years
Composite event of death, myocardial, stroke or repeat revascularization
Time frame: 5 years
Composite event of death, myocardial, stroke or repeat revascularization
Time frame: 10 years
Event rate of Procedural success
Procedural success is defined as \< 30% final stenosis and the absence of in-hospital event including death, Q-wave myocardial infarction or urgent repeat revascularization.
Time frame: 5 days
Plan to share: Undecided
No publications or documents are linked to this record.
This study is terminated, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seung-Jung Park